ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/26 | 1,147 | 1,173 | 1,146 | 1,151 | +2 | +0.2% | 529,800 |
| 2022/05/25 | 1,158 | 1,173 | 1,147 | 1,149 | -30 | -2.5% | 532,300 |
| 2022/05/24 | 1,208 | 1,220 | 1,177 | 1,179 | -59 | -4.8% | 865,600 |
| 2022/05/23 | 1,187 | 1,238 | 1,185 | 1,238 | +60 | +5.1% | 663,300 |
| 2022/05/20 | 1,149 | 1,184 | 1,146 | 1,178 | +50 | +4.4% | 497,900 |
| 2022/05/19 | 1,121 | 1,139 | 1,117 | 1,128 | -34 | -2.9% | 750,900 |
| 2022/05/18 | 1,155 | 1,176 | 1,145 | 1,162 | +11 | +1% | 436,000 |
| 2022/05/17 | 1,160 | 1,160 | 1,133 | 1,151 | ±0 | ±0% | 442,400 |
| 2022/05/16 | 1,185 | 1,216 | 1,138 | 1,151 | +11 | +1% | 1,164,000 |
| 2022/05/13 | 1,132 | 1,151 | 1,121 | 1,140 | +38 | +3.4% | 927,800 |
| 2022/05/12 | 1,156 | 1,157 | 1,102 | 1,102 | -82 | -6.9% | 1,241,700 |
| 2022/05/11 | 1,162 | 1,201 | 1,153 | 1,184 | +22 | +1.9% | 768,700 |
| 2022/05/10 | 1,157 | 1,177 | 1,146 | 1,162 | -7 | -0.6% | 748,300 |
| 2022/05/09 | 1,195 | 1,204 | 1,165 | 1,169 | -41 | -3.4% | 944,200 |
| 2022/05/06 | 1,245 | 1,245 | 1,210 | 1,210 | -44 | -3.5% | 641,400 |
| 2022/05/02 | 1,261 | 1,267 | 1,246 | 1,254 | -23 | -1.8% | 470,800 |
| 2022/04/28 | 1,264 | 1,279 | 1,264 | 1,277 | +16 | +1.3% | 407,900 |
| 2022/04/27 | 1,245 | 1,263 | 1,232 | 1,261 | -6 | -0.5% | 522,300 |
| 2022/04/26 | 1,261 | 1,273 | 1,251 | 1,267 | +14 | +1.1% | 392,400 |
| 2022/04/25 | 1,240 | 1,268 | 1,238 | 1,253 | -4 | -0.3% | 621,700 |
| 2022/04/22 | 1,265 | 1,271 | 1,247 | 1,257 | -22 | -1.7% | 654,300 |
| 2022/04/21 | 1,267 | 1,287 | 1,263 | 1,279 | -4 | -0.3% | 695,500 |
| 2022/04/20 | 1,321 | 1,321 | 1,282 | 1,283 | -30 | -2.3% | 777,500 |
| 2022/04/19 | 1,329 | 1,348 | 1,311 | 1,313 | -21 | -1.6% | 580,800 |
| 2022/04/18 | 1,344 | 1,354 | 1,322 | 1,334 | -26 | -1.9% | 459,200 |
| 2022/04/15 | 1,368 | 1,370 | 1,348 | 1,360 | -32 | -2.3% | 573,800 |
| 2022/04/14 | 1,382 | 1,404 | 1,374 | 1,392 | +4 | +0.3% | 427,900 |
| 2022/04/13 | 1,362 | 1,391 | 1,361 | 1,388 | +22 | +1.6% | 544,100 |
| 2022/04/12 | 1,391 | 1,394 | 1,363 | 1,366 | -24 | -1.7% | 425,500 |
| 2022/04/11 | 1,414 | 1,419 | 1,377 | 1,390 | -34 | -2.4% | 507,500 |
| 2022/04/08 | 1,437 | 1,438 | 1,413 | 1,424 | -3 | -0.2% | 344,500 |
| 2022/04/07 | 1,397 | 1,440 | 1,391 | 1,427 | +35 | +2.5% | 778,800 |
| 2022/04/06 | 1,427 | 1,427 | 1,384 | 1,392 | -71 | -4.9% | 1,068,300 |
| 2022/04/05 | 1,467 | 1,469 | 1,423 | 1,463 | +23 | +1.6% | 667,200 |
| 2022/04/04 | 1,420 | 1,453 | 1,407 | 1,440 | +37 | +2.6% | 603,300 |
| 2022/04/01 | 1,410 | 1,410 | 1,385 | 1,403 | -12 | -0.8% | 496,100 |
| 2022/03/31 | 1,446 | 1,448 | 1,404 | 1,415 | -33 | -2.3% | 724,900 |
| 2022/03/30 | 1,470 | 1,472 | 1,433 | 1,448 | -6 | -0.4% | 802,300 |
| 2022/03/29 | 1,453 | 1,469 | 1,437 | 1,454 | +14 | +1% | 558,000 |
| 2022/03/28 | 1,487 | 1,487 | 1,426 | 1,440 | -49 | -3.3% | 872,000 |
| 2022/03/25 | 1,483 | 1,494 | 1,449 | 1,489 | +20 | +1.4% | 746,400 |
| 2022/03/24 | 1,454 | 1,472 | 1,434 | 1,469 | +7 | +0.5% | 520,200 |
| 2022/03/23 | 1,483 | 1,492 | 1,447 | 1,462 | -2 | -0.1% | 917,400 |
| 2022/03/22 | 1,494 | 1,494 | 1,456 | 1,464 | -26 | -1.7% | 502,400 |
| 2022/03/18 | 1,476 | 1,520 | 1,470 | 1,490 | +19 | +1.3% | 1,026,300 |
| 2022/03/17 | 1,476 | 1,477 | 1,439 | 1,471 | +25 | +1.7% | 891,800 |
| 2022/03/16 | 1,402 | 1,453 | 1,401 | 1,446 | +74 | +5.4% | 934,600 |
| 2022/03/15 | 1,363 | 1,388 | 1,342 | 1,372 | +11 | +0.8% | 826,700 |
| 2022/03/14 | 1,365 | 1,395 | 1,340 | 1,361 | -11 | -0.8% | 637,200 |
| 2022/03/11 | 1,392 | 1,396 | 1,347 | 1,372 | -19 | -1.4% | 636,800 |
751～
800
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| 栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
